AI assistant
AXA — Capital/Financing Update 2014
May 16, 2014
1135_iss_2014-05-16_87ac2419-c3d0-4486-bde6-cd7a76eec722.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
AXA PRESS RELEASE
PARIS, MAY 16, 2014
AXA announced the successful placement of EUR 1 billion undated subordinated notes
AXA announced today the successful placement of EUR 1 billion of Reg S undated subordinated notes to institutional investors. The initial spread over swap is 225 basis points. The initial coupon has been set at 3.875% per annum. It will be fixed until the first call date in October 2025 and reset thereafter every 11 years with a 100 basis points step-up.
Settlement of the notes is expected to take place on May 20, 2014.
The notes will be treated as capital from a regulatory and rating agencies' perspective within applicable limits. The transaction has been structured to comply with the eligibility criteria for the 50% perpetual subordinated debt limit under Solvency 1 and in order to be eligible as capital under Solvency II.
ABOUT THE AXA GROUP
Sulabh Kakkar: +33.1.40.75.48.91
The AXA Group is a worldwide leader in insurance and asset management, with 157,000 employees serving 102 million clients in 56 countries. In 2013, IFRS revenues amounted to Euro 91.2 billion and IFRS underlying earnings to Euro 4.7 billion. AXA had Euro 1,113 billion in assets under management as of December 31, 2013.
The AXA ordinary share is listed on compartment A of Euronext Paris under the ticker symbol CS (ISN FR 0000120628 – Bloomberg: CS FP – Reuters: AXAF.PA). AXA's American Depository Share is also quoted on the OTC QX platform under the ticker symbol AXAHY.
The AXA Group is included in the main international SRI indexes, such as Dow Jones Sustainability Index (DJSI) and FTSE4GOOD.
It is a founding member of the UN Environment Programme's Finance Initiative (UNEP FI) Principles for Sustainable Insurance and a signatory of the UN Principles for Responsible Investment.
THIS PRESS RELEASE IS AVAILABLE ON THE AXA GROUP WEBSITE
| Investor Relations : | +33.1.40.75.46.85 | Individual Shareholder Relations: | Media Relations: | |
|---|---|---|---|---|
| Andrew Wallace-Barnett:+33.1.40.75.46.85 | +33.1.40.75.48.43 | Garance Wattez-Richard: | +33.1.40.75.46.42 | |
| Yael Beer-Gabel: | +33.1.40.75.47.93 | Hélène Caillet: | +33.1.40.75.55.51 | |
| Florian Bezault: | +33.1.40.75.59.17 | Jean-Baptiste Mounier: | +33.1.40.75.46.68 | |
| Varvara Romanenco: | +33.1.40.75.73.63 | |||
| Stéphanie Bonel: | +33.1.40.75.48.15 | |||
| Clémence Houssay: | +33.1.40.75.73.22 |
IMPORTANT LEGAL INFORMATION AND CAUTIONARY STATEMENTS CONCERNING FORWARD-LOOKING STATEMENTS Varvara Romanenco: +33.1.40.75.73.63
Certain statements contained herein are forward-looking statements including, but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and AXA's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. Please refer to the section "Cautionary statements" in page 2 of AXA's Document de Référence for the year ended December 31, 2013, for a description of certain important factors, risks and uncertainties that may affect AXA's business.
AXA undertakes no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information, future events or circumstances or otherwise.
This announcement is for information purposes only and does not constitute an offer to sell or a solicitation to purchase any securities in any jurisdiction. The securities referred to in this press release will not be offered to the public.
This press release is not an offer for sale within the United States of any security of AXA or any of its affiliates. Securities of AXA or any of its affiliates may not be offered or sold in the United States absent registration under U.S. securities laws or unless exempt from registration under such laws.